
基本信息:
- 专利标题: 3,4-DI-SUBSTITUTED CYCLOBUTENE-1, 2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS
- 专利标题(中):3,4-二异氰酸酯
- 申请号:EP03772075.2 申请日:2003-07-30
- 公开(公告)号:EP1539678A1 公开(公告)日:2005-06-15
- 发明人: TAVERAS, Arthur, G. , AKI, Cynthia, J. , CHAO, Jianping , DWYER, Michael , CHAO, Jianhua , YU, Younong , MERRITT, J., Robert , BIJU, Purakkattle , JAKWAY, James , LAI, Gaifa , WU, Minglang , HECKER, Evan, A. , LUNDELL, Daniel , FINE, Jay, S.
- 申请人: SCHERING CORPORATION , Pharmacopeia Drug Discovery, Inc.
- 申请人地址: 2000 Galloping Hill Road Kenilworth,New Jersey 07033-0530 US
- 专利权人: SCHERING CORPORATION,Pharmacopeia Drug Discovery, Inc.
- 当前专利权人: SCHERING CORPORATION,Pharmacopeia Drug Discovery, Inc.
- 当前专利权人地址: 2000 Galloping Hill Road Kenilworth,New Jersey 07033-0530 US
- 代理机构: UEXKÜLL & STOLBERG
- 优先权: US208412 20020730; US241326 20020911
- 国际公布: WO2004011418 20040205
- 主分类号: C07C237/36
- IPC分类号: C07C237/36 ; C07C237/44 ; C07C311/39 ; C07D207/323 ; C07D217/24 ; C07D307/52 ; C07D307/68 ; C07D307/81 ; C07D307/82 ; C07D307/83 ; C07D317/46 ; C07D319/18 ; C07D333/20 ; C07D405/12 ; C07D409/12 ; C07D409/14 ; C07D413/12 ; C07D413/14 ; A61K31/341 ; A61K31/36 ; A61K31/381
摘要:
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof. Also disclosed is the treatment of chemokine-mediated diseases using compounds of the formula (II)
摘要(中):
公开了可用于治疗趋化因子介导的疾病如急性和慢性炎症性疾病和癌症的具有下式的化合物或其药学上可接受的盐或溶剂合物。
公开/授权文献:
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07C | 无环或碳环化合物 |
------C07C237/00 | 羧酸酰胺,酸部分的碳架进一步被氨基取代 |
--------C07C237/02 | .羧酰胺基的碳原子连接在碳架的非环碳原子上 |
----------C07C237/36 | ..羧酰胺基的氮原子连接在被羧基取代的烃基的非环碳原子上 |